We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISTR icon
3626
Investar Holding Corp
ISTR
$414M
$3.87K ﹤0.01%
365
OCGN icon
3627
Ocugen
OCGN
$434M
$3.84K ﹤0.01%
9,593
-7,435
-44% -$3.67K
QNRX
3628
Quoin Pharmaceuticals
QNRX
$9.62M
$3.78K ﹤0.01%
26
+5
+24% +$1.04K
BELFA icon
3629
Bel Fuse Inc Class A
BELFA
$3.37B
$3.77K ﹤0.01%
80
ASYS icon
3630
Amtech Systems
ASYS
$272M
$3.75K ﹤0.01%
492
DNK
3631
DELISTED
Phoenix Tree Holdings Limited American Depositary Shares, each representing ten (10) Class A ordinar
DNK
$3.74K ﹤0.01%
1,580
CUK
3632
DELISTED
Carnival PLC
CUK
$3.72K ﹤0.01%
304
-690
-69% -$10.3K
BNGO icon
3633
Bionano Genomics
BNGO
$13.3M
$3.72K ﹤0.01%
20
-28
-58% -$7.34K
ESPR
3634
DELISTED
Esperion Therapeutics
ESPR
$3.71K ﹤0.01%
3,784
-3,353
-47% -$4.85K
CTV
3635
DELISTED
Innovid Corp.
CTV
$3.69K ﹤0.01%
2,885
-5,549
-66% -$6.49K
LFVN icon
3636
LifeVantage
LFVN
$85.3M
$3.59K ﹤0.01%
556
FRD icon
3637
Friedman Industries
FRD
$317M
$3.54K ﹤0.01%
264
ABSI icon
3638
Absci
ABSI
$1.51B
$3.53K ﹤0.01%
2,676
-4,153
-61% -$7.27K
RLMD icon
3639
Relmada Therapeutics
RLMD
$527M
$3.52K ﹤0.01%
1,174
-2,274
-66% -$6.75K
VIOT
3640
Viomi Technology
VIOT
$49.2M
$3.37K ﹤0.01%
3,340
UPLD icon
3641
Upland Software
UPLD
$15.4M
$3.36K ﹤0.01%
73
-195
-73% -$7.11K
EGIO
3642
DELISTED
Edgio, Inc. Common Stock
EGIO
$3.35K ﹤0.01%
98
-155
-61% -$4.85K
CCCC icon
3643
C4 Therapeutics
CCCC
$412M
$3.33K ﹤0.01%
1,791
-2,256
-56% -$6.88K
TRML
3644
DELISTED
Tourmaline Bio
TRML
$3.27K ﹤0.01%
116
-234
-67% -$6.85K
EXPR
3645
DELISTED
Express, Inc.
EXPR
$3.27K ﹤0.01%
363
-180
-33% -$2.19K
ACR
3646
ACRES Commercial Realty
ACR
$108M
$3.25K ﹤0.01%
392
NEXN
3647
Nexxen International
NEXN
$607M
$3.23K ﹤0.01%
915
+485
+113% +$2.68K
VRNA
3648
DELISTED
Verona Pharma
VRNA
$3.23K ﹤0.01%
198
+45
+29% +$867
AQN icon
3649
Algonquin Power & Utilities
AQN
$4.42B
$3.22K ﹤0.01%
544
-320
-37% -$2.41K
STKH
3650
Steakholder Foods
STKH
$1.11M
$3.2K ﹤0.01%
+3
New +$3.71K

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.